Sylvia E Hartl - Epidemiology

Author Information

Sylvia E. Hartl is a prominent researcher affiliated with the Second Department of Respiratory and Critical Care Medicine and the Ludwig Boltzmann Institute for COPD and Respiratory Epidemiology at Otto Wagner Hospital in Vienna, Austria. Her work primarily focuses on respiratory and critical care medicine, with a particular emphasis on epidemiological studies related to lung diseases.

Research Contributions

Sylvia E. Hartl has made significant contributions to the field of respiratory epidemiology. Her research has covered a wide range of topics, including blood eosinophil counts in the general population, aero-allergen sensitization, COPD diagnosis, and the impact of body composition on dyslipidemia in children and adolescents. Notably, she has also examined the seroprevalence of SARS-CoV-2 in Austria and provided insights into early anti-inflammatory therapy for respiratory conditions. Her work is highly cited, reflecting its impact on the scientific community.

Aliases

Sylvia E. Hartl is also known by several aliases, including S Hartl, S. Hartl, Sylvia Hartl.

Publication and Citation Metrics

Metric	Value
Total Citations	3970
h-index	24
Total Papers	112

Publications:

Blood eosinophil counts in the general population and airways disease: a comprehensive review and meta-analysis

DOI: 10.1183/13993003.04590-2020

Year: 2022

Aero-Allergen Sensitization in the General Population: Longitudinal Analyses of the LEAD (Lung Heart Social Body) Study

DOI: 10.2147/JAA.S349614

Year: 2022

COPD Diagnosis: Time for Disruption

DOI: 10.3390/jcm10204660

Year: 2021

Aero-allergen sensitization in a general population: data from the LEAD population cohort study

DOI: 10.1183/13993003.congress-2021.pa3114

Year: 2021

Low SARS-CoV-2 seroprevalence in the Austrian capital after an early governmental lockdown

DOI: 10.1038/s41598-021-89711-5

Year: 2021

New insights from GINA 2019/2020—Focus on early anti-inflammatory therapy

DOI: 10.1007/s00508-021-01830-1

Year: 2021

Using Body Composition Groups to Identify Children and Adolescents at Risk of Dyslipidemia

DOI: 10.3390/children8111047

Year: 2021

Late Breaking Abstract - Validation of the 2021 GLI reference equations for static lung volumes in a general European cohort

DOI: 10.1183/13993003.congress-2021.oa2562

Year: 2021

Appendicular lean mass - a driver of low lung function in children? Data from the population-based LEAD (Lung, hEart, sociAl, boDy) cohort

DOI: 10.1183/13993003.congress-2021.pa2029

Year: 2021

Changes in lung function in European adults born between 1884 and 1996 and implications for the diagnosis of lung disease: a cross-sectional analysis of ten population-based studies.

DOI: 10.1016/S2213-2600(21)00313-1

Year: 2021

Why are Gloves Important in Epidemiology?

How is Location Data Collected?

How Does Stigma Affect Public Health Interventions?

How Does Wolbachia Affect Hosts?

What is a Pandemic Response Plan?

What is Quantum Sensing?

What Are the Limitations of Using Mitochondrial DNA in Epidemiological Studies?

What is Nicotine Addiction?

Why is Population-Based Data Important?

Can Targeting the ACE2 Receptor Help in Disease Prevention and Treatment?

Partnered Content Networks

Relevant Topics